3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
4
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
10
Esophageal Neoplasms
4
Neoplasms
3
Urinary Bladder Neoplasms
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Oesophago-gastric Cancer
1
KRAS and NRAS Wild-type Colorectal Cancer
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Cone Dystrophy 3
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Breast Neoplasms
1
Advanced Colorectal Cancer
1
Adenocarcinoma Of Esophagus
1
Adenocarcinoma
1
Interventions
Capecitabine
3
Fluorouracil
2
Cetuximab
2
Bevacizumab
2
aflibercept
1
Panitumumab
1
Oxaliplatin
1
Nivolumab
1
Methotrexate
1
Leucovorin
1
Hypnosis
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Colorectal Cancer Metastatic
×
Panitumumab
×
Clear all
NCT06332079
2026-01-05
HAITI
Gruppo Oncologico del Nord-Ovest
Phase 2
Terminated
4 enrolled